Atlantic Healthcare granted new U.S. composition of matter patent for alicaforsen
Cambridge, UK; 25th January 2022. For Immediate Release Atlantic Healthcare plc…
Atlantic Healthcare is honoured to speak at the Middle East Investor Relations Associations Conference, Dubai and Attend the Future Investment Initiative, Riyadh
Cambridge, UK; 19th October 2021. For Immediate Release Atlantic Healthcare…
Atlantic Healthcare strengthens Board with seasoned industry veterans Robert Dow and Julian Thurston
Cambridge, UK; 7th June 2021 Atlantic Healthcare plc (Atlantic Healthcare), the…
Atlantic Healthcare attends virtual Digestive Disease Week®
Cambridge, UK; 24th May 2021 Atlantic Healthcare plc (“Atlantic Healthcare” or…
Atlantic Healthcare to attend IBD UK conference
Cambridge, UK; 26th April 2021 Atlantic Healthcare plc to attend a…
The effects of renzapride, a novel prokinetic agent, in diabetic gastroparesis
Mackie ADR, Ferrington C, Cowan S & Palmer KR. (1991) Alimentary…
Effects of cisapride in patients with cystic fibrosis and distal intestinal obstruction syndrome
Koletzko, S., Corey, M., Ellis, L., Spino, M., Stringer, D. A., & Durie, P.…
Is Gastroparesis Found More Frequently in Patients with Cystic Fibrosis? A Systematic Review
Corral JE, Corey WD, Mascarenhas MR, Barkin JS, Salathe M & Moshiree B…
Minimally Important Differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument
Khanna, D. et al. (2011) Journal of Rheumatology, 38(9), pp. 1920–1924. doi:…
Autonomic nervous system and smooth muscle cell involvement in systemic sclerosis: ultrastructural study of 3 cases
Malandrini, A. et al. (2010) The Journal of Rheumatology, 27(5), pp. 1203–…